Ameriprise Financial Inc. (AMP)

Ameriprise Financial shares sit 9.17% below their 52-week high of $572.56 after a quarter that beat on revenue but missed on earnings per share. The stock has still held above its 50-day, 20-day and 200-day averages, and at 11.71 times trailing earnings it trades at a steep discount to the sector. For investors, the question now is whether the valuation gap and steady profitability outweigh analysts' cautious stance, which leans toward Hold with a recent downgrade to Underperform from Buy.

Ameriprise reported adjusted earnings of $11.26 per share on October 29, 2026, short of the $11.77 analysts had expected, a miss of 4.33%. The stock fell 1.42% in the first session afterward. The shortfall stands out against the rest of the earnings record: the company beat estimates in six of its last eight reports, including the April 23, 2026 report, where earnings came in 10.28% above forecast. Revenue grew 12.91% in the latest quarter compared with a year earlier, faster than the sector median of 11.7%, so the miss came from earnings rather than sales.

At 11.71 times trailing earnings, the stock trades 41.0% below the sector median P/E of 16.5, and its price-to-sales ratio of 2.24 sits 39.2% below the sector median of 3.8. Trailing reported earnings per share are $44.40. The discount is the main reason the CleaRank score leans positive, but it also reflects investor caution: the stock has returned 11.86% over the past year, yet it is 5.45% above its 200-day average only in part because analysts have been trimming their views.

Of 14 analysts with a current rating, four rate the stock buy or strong buy, eight hold and two sell or strong sell, giving a consensus of Hold. Three months ago five of 14 rated it buy. On October 19, 2026, B of A Securities downgraded the stock to Underperform from Buy, and Morgan Stanley kept its Underweight rating on October 9, 2026. Evercore ISI Group kept its In-Line rating on October 30, 2026, the day after the report.

Insiders sold $71.7 million of stock over the last 18 months in 14 sales, and made no open-market purchases. Such sales are often planned in advance or made to cover taxes on vesting shares, so they carry less weight than buying by insiders would, but the absence of any purchases is a point investors weigh alongside the analyst downgrades.

Our base case is that the stock keeps trading in the upper half of its 52-week range while the market weighs a earnings-per-share shortfall against a low multiple. Analysts expect earnings per share to grow 17.4% this year to $46.11 and 11.7% next year to $51.50, which gives the bull case its foundation if those estimates hold. The median 12-month analyst target is $525.00, only 0.9% above the price, so the consensus sees limited upside from here. A move toward the $572.56 high would likely need another quarter where earnings meet or beat estimates. The range of targets, from $447.00 to $638.00, shows how far analysts disagree about the business.

Support sits first at the 50-day simple moving average of $512.78, the nearest level below the price, followed by the 20-day exponential moving average of $506.37. The 200-day simple moving average at $493.17 is the next floor, and the 52-week low of $422.37 marks the bottom of the year's range. On the upside, the 52-week high of $572.56 is the nearest level above the price and would be the first resistance a rally meets.